Antrobus J, Mackinnon B, Melia E, Hughes J, Parsons J
Cancers (Basel). 2024; 16(23).
PMID: 39682293
PMC: 11640432.
DOI: 10.3390/cancers16234108.
Seane E, Nair S, Vandevoorde C, Bisio A, Joubert A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598379
PMC: 11597529.
DOI: 10.3390/ph17111467.
Vu E, Karkache I, Pham A, Koroth J, Bradley E
J Cell Mol Med. 2024; 28(17):e70081.
PMID: 39261913
PMC: 11390340.
DOI: 10.1111/jcmm.70081.
Cassandri M, Porrazzo A, Pomella S, Noce B, Zwergel C, Aiello F
Cell Death Discov. 2024; 10(1):351.
PMID: 39107280
PMC: 11303816.
DOI: 10.1038/s41420-024-02115-y.
Watson N, Kuppuswamy S, Ledford W, Sukumari-Ramesh S
Front Immunol. 2024; 15:1419685.
PMID: 39050859
PMC: 11266039.
DOI: 10.3389/fimmu.2024.1419685.
Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.
Jung M, Nicholas N, Grindrod S, Dritschilo A
PLoS One. 2024; 19(7):e0306168.
PMID: 39008483
PMC: 11249239.
DOI: 10.1371/journal.pone.0306168.
Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury.
Shahror R, Shosha E, Morris C, Wild M, Mu S, Csanyi G
J Neuroinflammation. 2024; 21(1):170.
PMID: 38997746
PMC: 11241909.
DOI: 10.1186/s12974-024-03159-8.
Epigenetics.
Jain R, Epstein J
Adv Exp Med Biol. 2024; 1441:341-364.
PMID: 38884720
DOI: 10.1007/978-3-031-44087-8_18.
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods.
Curcio A, Rocca R, Alcaro S, Artese A
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794190
PMC: 11124352.
DOI: 10.3390/ph17050620.
Endocardial HDAC3 is required for myocardial trabeculation.
Jang J, Bentsen M, Kim Y, Kim E, Garg V, Cai C
Nat Commun. 2024; 15(1):4166.
PMID: 38755146
PMC: 11099086.
DOI: 10.1038/s41467-024-48362-6.
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator.
Karati D, Mukherjee S, Roy S
Med Oncol. 2024; 41(4):84.
PMID: 38438564
DOI: 10.1007/s12032-024-02303-x.
The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos.
Shao R, Suzuki T, Suyama M, Tsukada Y
BMC Genomics. 2024; 25(1):143.
PMID: 38317092
PMC: 10840191.
DOI: 10.1186/s12864-024-10029-3.
Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression.
Zhigulev A, Norberg Z, Cordier J, Spalinskas R, Bassereh H, Bjorn N
Life Sci Alliance. 2024; 7(3).
PMID: 38228368
PMC: 10796589.
DOI: 10.26508/lsa.202302244.
Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2.
Xu Y, Zhu Y, Wu Z, Li S, Shao M, Tao Q
BMC Cancer. 2023; 23(1):906.
PMID: 37752418
PMC: 10521566.
DOI: 10.1186/s12885-023-11393-1.
The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury.
Shosha E, Shahror R, Morris C, Xu Z, Lucas R, McGee-Lawrence M
Cell Death Dis. 2023; 14(9):621.
PMID: 37735154
PMC: 10514323.
DOI: 10.1038/s41419-023-06147-7.
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases.
Paluvai H, Shanmukha K, Tyedmers J, Backs J
Front Mol Biosci. 2023; 10:1190094.
PMID: 37674539
PMC: 10477789.
DOI: 10.3389/fmolb.2023.1190094.
Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells.
Tsai F, Huang H, Lai M, Liou J, Pan S, Yang C
Int J Mol Sci. 2023; 24(16).
PMID: 37628767
PMC: 10454243.
DOI: 10.3390/ijms241612588.
Separation of transcriptional repressor and activator functions in Drosophila HDAC3.
Tang M, Regadas I, Belikov S, Shilkova O, Xu L, Wernersson E
Development. 2023; 150(15).
PMID: 37455638
PMC: 10445730.
DOI: 10.1242/dev.201548.
Targeting histone deacetylases for cancer therapy: Trends and challenges.
Liang T, Wang F, Elhassan R, Cheng Y, Tang X, Chen W
Acta Pharm Sin B. 2023; 13(6):2425-2463.
PMID: 37425042
PMC: 10326266.
DOI: 10.1016/j.apsb.2023.02.007.
NKAP acts with HDAC3 to prevent R-loop associated genome instability.
Zhang X, Duan J, Li Y, Jin X, Wu C, Yang X
Cell Death Differ. 2023; 30(7):1811-1828.
PMID: 37322264
PMC: 10307950.
DOI: 10.1038/s41418-023-01182-5.